RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: vitiligo
Accession: DOID:12306
browse the term
Definition: An autoimmune disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes. (DO)
Synonyms: exact_synonym: SLEV1; VTLG; vitiligo-related systemic lupus erythematosus
related_synonym: AIS1; AIS2; AIS3; AIS4; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 1p-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 4-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 7-RELATED; AUTOIMMUNE DISEASE SUSCEPTIBILITY LOCUS, CHROMOSOME 8-RELATED; Autoimmune Disease, Susceptibility To, 1; Autoimmune Disease, Susceptibility To, 2; Autoimmune Disease, Susceptibility To, 3; Autoimmune Disease, Susceptibility To, 4; VAMAS1; VAMAS2; VAMAS3; VAMAS4; VAMAS5; VAMAS6; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 2; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 3; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 4; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 5; Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6
primary_id: MESH:D014820
alt_id: MIM:193200 ; MIM:606579 ; MIM:607836 ; MIM:608391 ; MIM:608392 ; MIM:609400
xref: EFO:0004208 ; GARD:10751 ; ICD10CM:L80 ; ICD9CM:709.01 ; NCI:C26915
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Bach2
BTB domain and CNC homolog 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624799:3,893,548...4,262,344
Ensembl chrNW_004624799:3,984,546...4,256,898
G
C3
complement C3
ISO
RGD
PMID:12121667
RGD:7401277
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
G
Casp7
caspase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624737:32,853,354...32,888,881
Ensembl chrNW_004624737:32,852,835...32,887,069
G
Cat
catalase
susceptibility no_association
ISO
DNA:SNP,haplotype:promoter,cds:-89A>T,389C>T(human) DNA:SNPs:promoter,exon: -89A>T rs7943316), 389C>T (rs769217)(human) protein:decreased activity:skin:
RGD
PMID:19439879 PMID:20613769 PMID:23868633
RGD:9479149 RGD:9479150 RGD:9479169
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
G
Ccr6
C-C motif chemokine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chrNW_004624785:12,190,802...12,203,924
G
Cd44
CD44 molecule (IN blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624767:11,938,452...12,024,970
Ensembl chrNW_004624767:11,938,028...12,025,069
G
Cd80
CD80 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624731:28,630,540...28,655,297
Ensembl chrNW_004624731:28,630,446...28,651,994
G
Clnk
cytokine dependent hematopoietic cell linker
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624755:20,667,325...20,817,497
G
Clu
clusterin
ISO
RGD
PMID:7558712
RGD:8699503
NCBI chrNW_004624758:22,431,331...22,444,185
Ensembl chrNW_004624758:22,426,918...22,444,357
G
Comt
catechol-O-methyltransferase
no_association
ISO
DNA:polymorphism: :p.V158M (human)
RGD
PMID:19112571 PMID:24915010
RGD:8662333 RGD:8662336
NCBI chrNW_004624747:569,127...588,479
Ensembl chrNW_004624747:581,832...588,333
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
no_association susceptibility
ISO
associated with Autoimmune Diseases;DNA:polymorphisms: : DNA:SNPs:multiple: DNA:SNP:3'UTR:rs3087243(human) DNA:SNP:exon:+49A>G rs231775)(human)
RGD
PMID:15649153 PMID:18200060 PMID:19129082 PMID:21794098
RGD:7411687 RGD:7411696 RGD:7411697 RGD:7411699
NCBI chrNW_004624765:12,449,205...12,454,324
Ensembl chrNW_004624765:12,449,205...12,454,324
G
Esr1
estrogen receptor 1
susceptibility no_association
ISO
DNA:SNP:intron DNA:SNP:exon
RGD
PMID:15381239
RGD:8552976
NCBI chrNW_004624785:6,164,507...6,601,302
Ensembl chrNW_004624785:6,164,379...6,601,326
G
Foxp1
forkhead box P1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20526340
NCBI chrNW_004624773:5,543,529...6,076,522
Ensembl chrNW_004624773:5,543,536...5,883,131
G
Hgf
hepatocyte growth factor
treatment
ISO
RGD
PMID:16117796
RGD:8548598
NCBI chrNW_004624739:30,233,589...30,307,508
Ensembl chrNW_004624739:30,236,146...30,307,356
G
Ifih1
interferon induced with helicase C domain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624732:3,187,791...3,248,795
Ensembl chrNW_004624732:3,187,791...3,250,981
G
Ifng
interferon gamma
onset susceptibility
ISO
DNA:polymorphism:intron:rs2430561(human) DNA:repeats:intron:rs3138557(human)
RGD
PMID:23777204
RGD:8157616
NCBI chrNW_004624802:163,261...166,534
Ensembl chrNW_004624802:163,261...166,534
G
Ikzf4
IKAROS family zinc finger 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624802:12,008,096...12,023,142
Ensembl chrNW_004624802:12,007,506...12,023,121
G
Il13
interleukin 13
treatment
ISO
RGD
PMID:23680073
RGD:8549591
NCBI chrNW_004624733:39,427,189...39,430,019
Ensembl chrNW_004624733:39,428,095...39,429,843
G
Il17a
interleukin 17A
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chrNW_004624855:3,911,349...3,914,214
Ensembl chrNW_004624855:3,911,349...3,913,136
G
Il1a
interleukin 1 alpha
ISO
protein:increased expression:skin CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chrNW_004624749:12,795,967...12,805,658
Ensembl chrNW_004624749:12,795,946...12,805,154
G
Il2
interleukin 2
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chrNW_004624777:2,885,537...2,890,453
Ensembl chrNW_004624777:2,885,535...2,890,453
G
Il4
interleukin 4
ISO
protein:increased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chrNW_004624733:39,412,800...39,420,079
G
Itk
IL2 inducible T cell kinase
ISO
ClinVar Annotator: match by term: Vitiligo-associated multiple autoimmune disease susceptibility 1
ClinVar
PMID:28492532 PMID:32628964 PMID:32888943
NCBI chrNW_004624733:32,125,005...32,198,901
Ensembl chrNW_004624733:32,127,388...32,198,869
G
Kif1b
kinesin family member 1B
ISO
ClinVar Annotator: match by term: Vitiligo
ClinVar
PMID:25741868 PMID:28492532
NCBI chrNW_004624818:2,282,999...2,428,586
Ensembl chrNW_004624818:2,282,999...2,428,563
G
LOC101703821
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphisms (human) DNA:polymorphism:HLA-DQB1*0201(human)
RGD
PMID:9653015 PMID:16420246
RGD:36174006 RGD:5147644
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
G
Mbl2
mannose binding lectin 2
susceptibility no_association
ISO
DNA:polymorphism:exon: DNA:polymorphisms:promoter, exon:
RGD
PMID:17337399 PMID:19416237
RGD:8693723 RGD:8693724
NCBI chrNW_004624791:10,881,319...10,886,294
Ensembl chrNW_004624791:10,881,268...10,886,297
G
Mc1r
melanocortin 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624746:131,356...137,745
Ensembl chrNW_004624746:132,904...133,860
G
Nfe2l2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chrNW_004624787:14,355,330...14,381,353
Ensembl chrNW_004624787:14,355,791...14,381,251
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28836394
NCBI chrNW_004624815:1,290,106...1,376,961
Ensembl chrNW_004624815:1,289,997...1,369,610
G
Psmb9
proteasome 20S subunit beta 9
ISO
RGD
PMID:14551602
RGD:1578358
NCBI chrNW_004624754:23,811,008...23,815,432
Ensembl chrNW_004624754:23,807,272...23,815,417
G
Ptpn22
protein tyrosine phosphatase non-receptor type 22
ISO
DNA:polymorphism: :1858C>T (p.R620W) (human) DNA: snp : cds: rs2476601
RGD
PMID:16015369 PMID:18426414
RGD:6484552 RGD:7829737
NCBI chrNW_004624772:9,472,869...9,552,751
Ensembl chrNW_004624772:9,472,913...9,550,990
G
Sh2b3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624747:20,729,142...20,759,631
Ensembl chrNW_004624747:20,730,751...20,759,625
G
Sla
Src like adaptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624735:22,929,467...22,949,471
Ensembl chrNW_004624735:22,892,713...22,950,355
G
Sod2
superoxide dismutase 2
disease_progression
ISO
DNA, mRNA, protein:SNPs, increased expression:cds:p.L84F (rs11575993), p.T58I (rs35289490), skin, leukocyte (human)
RGD
PMID:24036105
RGD:8547522
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
G
Tgfb1
transforming growth factor beta 1
ISO
protein:decreased expression:serum:
RGD
PMID:22342018
RGD:8663475
NCBI chrNW_004624907:162,567...175,696
Ensembl chrNW_004624907:161,569...176,605
G
Tlr2
toll like receptor 2
susceptibility
ISO
DNA:polymorphism:exon:p.R753Q(human)
RGD
PMID:22429552
RGD:7777152
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
G
Tlr4
toll like receptor 4
susceptibility
ISO
DNA:polymorphism:exon:p.D299G(human)
RGD
PMID:22429552
RGD:7777152
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:skin
CTD RGD
PMID:16911396 PMID:28836394
RGD:7794736
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
Tob2
transducer of ERBB2, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22561518
NCBI chrNW_004624752:7,129,464...7,190,718
Ensembl chrNW_004624752:7,129,550...7,140,668
G
Tyr
tyrosinase
severity
ISO
RGD
PMID:8697641 PMID:22834951
RGD:8694387 RGD:8694409
NCBI chrNW_004624845:844,492...933,098
Ensembl chrNW_004624845:844,293...933,098
G
Vdr
vitamin D receptor
no_association
ISO
DNA:SNPs, haplotype: :multiple DNA:SNP:exon:rs2228570 (human) DNA:SNPs: :rs731236, rs1544410, rs7975232 (human)
RGD
PMID:22738935 PMID:22762534
RGD:8158061 RGD:8158066
NCBI chrNW_004624816:4,314,146...4,423,946
Ensembl chrNW_004624816:4,365,961...4,424,514
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Dstyk
dual serine/threonine and tyrosine protein kinase
ISO
ClinVar Annotator: match by term: DSTYK-related condition | ClinVar Annotator: match by term: Hereditary spastic paraplegia 23
OMIM ClinVar
PMID:17273976 PMID:23862974 PMID:25741868 PMID:27657687 PMID:28492532 PMID:28566479 PMID:33624863 More...
NCBI chrNW_004624807:5,942,610...5,993,049
Ensembl chrNW_004624807:5,942,799...5,993,049
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all